In the past few years, we have demonstrated the efficacy of a nanoparticle system, super carbonate apatite (sCA), for the in vivo delivery of siRNA/miRNA. Intravenous injection of sCA loaded with small RNAs results in safe, high tumor delivery in mouse models. To further improve the efficiency of tumor delivery and avoid liver toxicity, we successfully developed an inorganic nanoparticle device (iNaD) via high-frequency ultrasonic pulverization combined with PEG blending during the production of sCA. Compared to sCA loaded with 24 μg of miRNA, systemic administration of iNaD loaded with 0.75 μg of miRNA demonstrated similar delivery efficiency to mouse tumors with little accumulation in the liver. In the mouse therapeutic model, iNaD loaded...
Specific gene knockdown facilitated by short interfering RNA (siRNA) is a potential approach for sup...
RNA interference (RNAi) has considerable potential as a therapeutic strategy, but the development of...
RNA interference (RNAi) is a process in which small non-coding, double-stranded RNA (dsRNA) regulate...
RNA interference (RNAi) technology is currently being tested in clinical trials for a limited number...
<div><p>RNA interference (RNAi) technology is currently being tested in clinical trials for a limite...
Introduction: Cancer is one of the top-ranked noncommunicable diseases causing deaths to nine millio...
Harnessing siRNA technology has promising results in limiting the proliferation and survival of canc...
Development of nontoxic, tumor-targetable, and potent <i>in vivo</i> RNA delivery systems remains an...
The present study describes hybrid nanoparticles, built by alternate deposition of siRNA and modifie...
International audienceThe present study describes hybrid nanoparticles, built by alternate depositio...
A lipid coated calcium phosphate (LCP) nanoparticle (NP) formulation was developed for efficient del...
The use of nucleic acid to control the expression of genes relevant to tumor progression is a key th...
Gene augmentation therapy entails replacement of the abnormal tumor suppressor genes in cancer cells...
Targeted delivery of RNA-based therapeutics for cancer therapy remains a challenge. We have develope...
Specific gene knockdown facilitated by short interfering RNA (siRNA) is a potential approach for sup...
Specific gene knockdown facilitated by short interfering RNA (siRNA) is a potential approach for sup...
RNA interference (RNAi) has considerable potential as a therapeutic strategy, but the development of...
RNA interference (RNAi) is a process in which small non-coding, double-stranded RNA (dsRNA) regulate...
RNA interference (RNAi) technology is currently being tested in clinical trials for a limited number...
<div><p>RNA interference (RNAi) technology is currently being tested in clinical trials for a limite...
Introduction: Cancer is one of the top-ranked noncommunicable diseases causing deaths to nine millio...
Harnessing siRNA technology has promising results in limiting the proliferation and survival of canc...
Development of nontoxic, tumor-targetable, and potent <i>in vivo</i> RNA delivery systems remains an...
The present study describes hybrid nanoparticles, built by alternate deposition of siRNA and modifie...
International audienceThe present study describes hybrid nanoparticles, built by alternate depositio...
A lipid coated calcium phosphate (LCP) nanoparticle (NP) formulation was developed for efficient del...
The use of nucleic acid to control the expression of genes relevant to tumor progression is a key th...
Gene augmentation therapy entails replacement of the abnormal tumor suppressor genes in cancer cells...
Targeted delivery of RNA-based therapeutics for cancer therapy remains a challenge. We have develope...
Specific gene knockdown facilitated by short interfering RNA (siRNA) is a potential approach for sup...
Specific gene knockdown facilitated by short interfering RNA (siRNA) is a potential approach for sup...
RNA interference (RNAi) has considerable potential as a therapeutic strategy, but the development of...
RNA interference (RNAi) is a process in which small non-coding, double-stranded RNA (dsRNA) regulate...